M. Diaz-Curiel

TL;DR: In this 4- and 5-year study, strontium ranelate is an effective and safe treatment for long-term treatment of osteoporosis in postmenopausal women.

TL;DR: It is expected that the use of the reference standard will help resolve difficulties in the comparison of results between studies and the comparative assessment of new technologies.

TL;DR: During 3-yr strontium ranelate treatment, an increase in femoral neck BMD was associated with a proportional reduction in vertebral fracture incidence.

TL;DR: The effects of strontium ranelate on BMD in osteoporotic men were similar to those in postmenopausal osteopootic women, supporting its use in the treatment of osteoporeosis in men.

TL;DR: Long-term treatment with strontium ranelate is associated with sustained increases in BMD over 10 years, with a good safety profile, and results also support the maintenance of antifracture efficacy over 10-years with Strontium runelate.